▶ Plasmapp will start full-scale sales in the domestic dental market by satisfying Osstem Implant's performance verification and customer satisfaction evaluation

Plasmapp (405000), a bio plasma deep-tech company, announced on the 22nd that it has signed a contract to supply plasma sterilizers to Osstem Implant on the 19th.

Following the recent signing of contracts with the largest global distributors of STERLINK lite plus (overseas brand name: STERLINK U510) in the U.S. and Japan, Plasmapp has successfully signed a supply contract with Osstem Implant, the largest distributor in the dental market. Osstem Implant has shown great interest in Plasmapp's new product since last year and started to consider its introduction, it received good evaluations in the performance verification and customer satisfaction evaluations of Osstem Implant's research and marketing as it was certified by the Ministry of Food and Drug Safety at the end of last year. Preparations for the product launch have already been completed and supply will begin at the end of April.

“The successful supply contract with Osstem Implant, the largest distributor in Korea, has once again recognized the competitiveness of Plasmapp's technology,” said Youbong Lim, CEO of Plasmapp. “The largest dental distributor in the world has also recently started to consider introducing Plasmapp's sterilizer products, and we are working with global distributors on implant surface treatment solutions and new plasma stimulation treatment solutions.”

Plasmapp's (405000) medical low-temperature plasma sterilizer (brand: STERLINK) was the first non-U.S. company to receive U.S. FDA clearance in 2021 and remains the only U.S. FDA-cleared sterilizer among the world's compact plasma sterilizers, giving it a strong position in the global medical device market.

<"Plasmapp's sterilization solution, which won the top prize at the 'Red Dot Design Award 2024' for its ergonomic design providing high user convenience, Photo provided by Plasmapp">